IP Library Assignment 036809/0447
Patent Assignment
Reel/Frame 036809/0447

Assignment of Assignor's Interest

Recorded: 2015-10-16 Pages: 5
Assignor
ALKERMES, INC.
Executed: 2015-10-16
Assignee
ALKERMES PHARMA IRELAND LIMITED
1 BURLINGTON ROAD, CONNAUGHT HOUSE, DUBLIN, 4, IRELAND
Covered Properties (10)
Polymorphic Forms of Naltrexone
Patent: 7,279,579 →
Application: 10/860,608 →
Publication: US 2006/0142320
Naltrexone Long Acting Formulations and Methods of Use
Patent: 7,919,499 →
Application: 11/083,167 →
Publication: US 2005/0245558
Polymorphic Forms of Naltrexone
Patent: 8,389,540 →
Application: 11/860,677 →
Publication: US 2008/0227804
Naltrexone Long Acting Formulations and Methods of Use
Application: 13/037,713 →
Publication: US 2011/0212985
Polymorphic Forms of Naltrexone
Patent: 8,735,420 →
Application: 13/690,327 →
Publication: US 2013/0253199
Naltrexone Long Acting Formulations and Methods of Use
Application: 13/871,534 →
Publication: US 2014/0155424
Polymorphic Forms of Naltrexone
Patent: 8,975,272 →
Application: 14/249,613 →
Publication: US 2014/0303200
Polymorphic Forms of Naltrexone
Patent: 9,221,830 →
Application: 14/612,904 →
Publication: US 2015/0218178
Polymorphic forms of naltrexone
Application: 60/475,863 →
Naltrexone long acting formulations and methods of use
Application: 60/564,542 →
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger Oct 31, 2007
From: ALKERMES CONTROLLED THERAPEUTICS, II
To: ALKERMES, INC.
Reel/Frame 020035/0827 →
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Release of Patent Security Agreement (First Lien) Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
Security Interest Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
Security Interest Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
Release of Security Interest in Patents Previously Recorded at Reel/Frame (073213/0302) Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →